Magnesium for GLP-1-Related Sleep Disruption: The Glycinate Case

**Pregnancy and breastfeeding:** Consult your healthcare provider before taking this supplement during pregnancy or while nursing. The safety of supplemental doses beyond dietary intake has not been established in pregnant or lactating women. **Blood thinners:** If you take blood-thinning medications (e.g., warfarin, apixaban, rivaroxaban, clopidogrel, or high-dose aspirin), consult your healthcare provider BEFORE starting this supplement, as it may have additive antiplatelet or anticoagulant effects. **Kidney disease:** If you have chronic kidney disease (CKD) or any significant kidney impairment, consult your healthcare provider before taking this supplement. Some supplements can accumulate to dangerous levels when kidney function is reduced. This is particularly relevant for magnesium, which is renally cleared — magnesium accumulation in CKD can cause cardiac arrhythmias and neuromuscular depression. **Gout:** Individuals with gout should consult their healthcare provider before starting this supplement. Certain supplements (e.g., collagen, fish oil, niacin) may affect uric acid levels or trigger flares in susceptible individuals. **GLP-1 therapy interaction:** Discuss any supplement additions with your prescribing physician — GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) interact with gastric emptying and absorption. Supplement dosing or timing may need adjustment. In particular, the delayed gastric emptying induced by GLP-1 medications may alter the absorption kinetics of orally administered magnesium; clinical observation and dose titration are reasonable. **Medication interactions:** Magnesium can reduce the absorption of several common prescriptions — tetracycline and quinolone antibiotics, bisphosphonates, and levothyroxine — when taken at the same time. Separate magnesium dosing from these prescriptions by at least 2–4 hours. Magnesium also potentiates the effect of muscle relaxants and some blood pressure medications; review with the clinician who manages those prescriptions before starting nightly magnesium. **Supplemental upper intake limit (UL):** The Institute of Medicine / NIH Tolerable Upper Intake Level for supplemental magnesium is **350 mg/day** from supplements alone (food-source magnesium is not counted toward the UL). Staying at or below this UL keeps risk of dose-dependent GI side effects low. **Loose stools and diarrhea:** Magnesium at doses above the 350 mg UL — and especially above 400 mg elemental — commonly causes loose stools. In GLP-1 users already managing GI side effects this can compound diarrhea risk. Reduce the dose if loose stools are persistent. Severe diarrhea also accelerates magnesium loss — paradoxically lowering serum magnesium and worsening sleep symptoms — which is one reason this page recommends glycinate over citrate or oxide. **Severe sleep disruption:** If your sleep symptoms include suicidal ideation, severe daytime impairment, or symptoms consistent with obstructive sleep apnea (loud snoring, witnessed apneas, morning headache), magnesium is not a substitute for evidence-based evaluation and treatment. Seek clinician evaluation before relying on a mineral alone.